Evaluating only Nomi Health’s profile at its peak — without knowing the outcome — the model ranked Unit economics as the #1 likely cause. Documented cause: Market timing.
Key Events Timeline
FOUNDING
Founded as direct-to-employer healthcare platform in Utah
PIVOT
Pivoted to COVID testing; won government contracts
FUNDING
Ran 40M+ COVID tests; valuation reached $6B
PRODUCT LAUNCH
Federal COVID testing demand collapsed; revenue crater
SHUTDOWN
Workforce reduced 90%+; operations near-shutdown
Full Analysis
Free · no account needed
Documented cause
Nomi Health was a direct-to-employer healthcare platform founded in Utah in 2019. It pivoted aggressively to COVID testing in 2020, winning large government contracts and running tens of millions of tests nationwide. At its peak in 2021, the company reached a valuation of approximately $6 billion. When federal COVID testing demand collapsed in 2022, Nomi's revenue cratered almost overnight. The company eliminated over 90% of its workforce within months, going from one of Utah's most celebrated startups to near-shutdown in under two years.
Lesson
“Emergency government contracts are revenue, not a business. When the emergency ends, so does the revenue — and the valuation built on it.”